The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EBMT 2018 | EBMT 2018: Updates on advanced Hodgkin lymphoma treatment
Treatment of advanced Hodgkin lymphoma has evolved dramatically in the last 10 years, especially with the introduction of PET-response adapted treatment and the introduction of novel agents. Martin Hutchings, MD, PhD from Copenhagen University Hospital, Copenhagen, Denmark discusses the latest advances and how they have changed the way we treat advanced Hodgkin lymphoma. This video was recorded at the EBMT 2018 Annual Meeting, held in Lisbon, Portugal.
